Skip to main content
Premium Trial:

Request an Annual Quote

DSM to Use Ludesi's 2D Protein Gel-Analysis Software

NEW YORK (GenomeWeb News) — Swedish bioinformatics company Ludesi will provide its 2-D protein gel image-analysis software services to DSM, Ludesi said today.
 
The software will help DSM streamline the protein quantification step in its proteomics platform, which the company said will be a useful improvement in the company’s studies of microbial metabolism.
 
Financial terms of the agreement were not released.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.